Effect of Ciprofol Infusion for Induction and Maintenance on Hemodynamics and Postoperative Recovery

Launched by XIUMEI SONG · Dec 17, 2022

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a medication called Ciprofol, used during anesthesia, to see how it impacts blood flow and recovery after surgery for patients undergoing thoracoscopic lobectomy, a type of lung surgery. The goal is to find out if Ciprofol can help patients feel better and recover faster after their operation.

To participate in this study, you need to be between 18 and 65 years old, have a body mass index (BMI) between 20 and 30, and be scheduled for this specific type of surgery. If you have certain health issues, are allergic to the study medications, or are taking certain medications that could interfere with the study, you may not be eligible. Participants will receive the Ciprofol infusion during their surgery and will be monitored closely to see how well they recover afterward. This trial is currently recruiting participants, so it’s a great opportunity to contribute to important research in anesthesia and recovery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • American Society of Anesthesiology (ASA)Ⅰ～Ⅱ grade;
• • 18-65 years;
• • Body mass index (BMI) 20-30kg/m2 ;
• • Scheduled for thoracoscopic lobectomy under general anesthesia;
• Exclusion Criteria:
• • Refused to participate in the clinical study;
• • Predictable airway difficulties requiring awake intubation;
• • Allergy to the drugs which were used in this study;
• • Tracheal intubation failed for twice;
• • Patients with mental diseases or consciousness disorder;
• • long-term use of sedatives or Antidepressants;
• • Patients who are participating in other clinical studies.